ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Cell MedX Corporation (PK)

Cell MedX Corporation (PK) (CMXC)

0.0288
0.00
(0.00%)
Closed 09 December 8:00AM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
0.0288
Bid
0.0013
Offer
0.0295
Volume
-
0.00 Day's Range 0.00
0.003 52 Week Range 3.42
Market Cap
Previous Close
0.0288
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
8,240
Shares Outstanding
44,138,372
Dividend Yield
-
PE Ratio
-9.38
Earnings Per Share (EPS)
-0
Revenue
-
Net Profit
-142k

About Cell MedX Corporation (PK)

Cell MedX Corp. is a biotech company focused on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness and alleviate complications associated with medical conditions including, but not limited to:diabetes, Parkinson's disease, high ... Cell MedX Corp. is a biotech company focused on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness and alleviate complications associated with medical conditions including, but not limited to:diabetes, Parkinson's disease, high blood pressure, neuropathy and kidney function. Show more

Sector
Surgical,med Instr,apparatus
Industry
Surgical,med Instr,apparatus
Headquarters
Carson City, Nevada, USA
Founded
-
Cell MedX Corporation (PK) is listed in the Surgical,med Instr,apparatus sector of the OTCMarkets with ticker CMXC. The last closing price for Cell MedX (PK) was US$0.03. Over the last year, Cell MedX (PK) shares have traded in a share price range of US$ 0.003 to US$ 3.42.

Cell MedX (PK) currently has 44,138,372 shares in issue. The market capitalisation of Cell MedX (PK) is US$1.27 million. Cell MedX (PK) has a price to earnings ratio (PE ratio) of -9.38.

CMXC Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
12-0.4062-93.37931034480.4350.5250.184582400.35095864CS
26-0.6162-95.53488372090.6450.6450.093179270.39262392CS
520.02588600.0033.420.003348400.3974891CS
156-2.58195-98.89686871592.6107513.9681.5E-5260550.74300474CS
260-2.9712-99.04313.9681.5E-5433114.06439194CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AABVFAberdeen International Inc (PK)
US$ 0.0381
(0.00%)
0
AABKFAareal Bank AG (PK)
US$ 0.00
(0.00%)
0
AABBAsia Broadband Inc (PK)
US$ 0.0225
(0.00%)
0
AAALYAareal Bank AG (PK)
US$ 34.65
(0.00%)
0
AAAIFAlternative Investment Trust (PK)
US$ 0.55
(0.00%)
0
AABVFAberdeen International Inc (PK)
US$ 0.0381
(0.00%)
0
AABKFAareal Bank AG (PK)
US$ 0.00
(0.00%)
0
AABBAsia Broadband Inc (PK)
US$ 0.0225
(0.00%)
0
AAALYAareal Bank AG (PK)
US$ 34.65
(0.00%)
0
AAAIFAlternative Investment Trust (PK)
US$ 0.55
(0.00%)
0
AABVFAberdeen International Inc (PK)
US$ 0.0381
(0.00%)
0
AABKFAareal Bank AG (PK)
US$ 0.00
(0.00%)
0
AABBAsia Broadband Inc (PK)
US$ 0.0225
(0.00%)
0
AAALYAareal Bank AG (PK)
US$ 34.65
(0.00%)
0
AAAIFAlternative Investment Trust (PK)
US$ 0.55
(0.00%)
0

Discussion

View Full Feed
resx18 resx18 2 minutes ago
Wrong again Kool Aide boy
AURI
glenn1919 glenn1919 2 minutes ago
ZEO............................https://stockcharts.com/h-sc/ui?s=ZEO&p=W&b=5&g=0&id=p86431144783
ZEO
resx18 resx18 2 minutes ago
Good Morning AURI
AURI
asp42001 asp42001 3 minutes ago
iPhone Crypto AI Bitcoin & FiCentive ID Card FusioN

"One for ALL, ALL for One" .... Together they bargain divided they fail.

DEAL!
USIO
sab63090 sab63090 3 minutes ago
$AVXL needs acceptance, but a backdrop of stable performance in the overall market will help....The PPI on the 12th will help to decide whether Powell takes the pressure off on interest rates. It might be good to see how this Thursday's report of how a big consistent company is doing ($COST.)
AVXL COST
Trooperstocks Trooperstocks 3 minutes ago
$ILLR Triller Group will revamp our app discovery experience and content ecosystem with exclusive content from top creators.
ILLR
Hosai Hosai 4 minutes ago
He did indeed confuse things, unless this makes sense to you? -

"Again, this trial had two co-primary endpoints - ADAS-Cog13 and ADCS-ADL. Note that the trial did not meet the endpoint of ADCS-ADL. P-values for the 30mg and the 50mg cohorts came out to 0.354 and 0.527 - ie, not stati
AVXL
learningcurve2020 learningcurve2020 6 minutes ago
Les should call this guy. 

NWBO
don estaban don estaban 6 minutes ago
Very nice article lets get it right before Christmas
NLST
kenjiroo kenjiroo 7 minutes ago
Correct Pea.. that's whi this will never be happen .. remember his quote 'We anticipate the launch of VüMe in early Q1 of 2022" said Thomas.' we are almost 2025, so don't why we even talk about this APP .. even ST3 doesn't. Case closed IMO, I'm sure he will find somt new to keep us busy .. AGAIN
TPTW
TRAPPER JIM TRAPPER JIM 7 minutes ago
Went out to go to work today and my truck wouldn't start. Have to look at it tonight when I get home. Always something isn't it 
CherryTree1 CherryTree1 7 minutes ago
The NWBO DCVAX-L for GBM phase-3 had a primary endpoint is progression-free survival (PFS), with overall survival (OS) as a secondary endpoint. The only end point in any trial is overall survival. Other endpoints are often chosen if it is believed they can convince the regulatory agencies that they
NWBO
TheSprinx TheSprinx 8 minutes ago
Needs to be reposted 
 https://x.com/wwtp_consultant/status/1865333541577310409?s=46&t=FWyCU7KfIDokGToTtqinIg
HMBL
Invest-in-America Invest-in-America 10 minutes ago
MRM: Their cute "Mother Bracelet" starts at $144 --- just sold 25,000 of them via their PR.
MRM
Griff79 Griff79 11 minutes ago
I dont think I'm going to sleep this week! 🥳🥳
RDAR
No-Quarter No-Quarter 12 minutes ago
The last update I read said expect the change to come in early 2025. Nothing more specific.

...no more bell ringing on CNBC.
Investor2014 Investor2014 12 minutes ago
He is not confusing the P2a and P2b/3 AD trials and data. He is also right that according to Missling data from both trials is part of the MAA submission.
AVXL
sello sello 13 minutes ago
There is no change in the share structure. I was surprised considering the volume last week.
OWPC
flipper44 flipper44 13 minutes ago
Oh, a little different, but that’s the quote people have been discussing. I see, thanks for telling me where it was.

I just located that quote in context, and I like what she had to say right after that quote at the June 29, 2024 ASM. (Of course she had also essentially explained tha
ASM
Serpico2005 Serpico2005 14 minutes ago
This is the ONE !! Zip Code Changer 
Get your Moon Pants On $$$$$$$
RDAR
Ace Trader Ace Trader 14 minutes ago
RE-COIL DAY !!
The Full Socatics line has crossed and the CCI line has shown reversal and heading back to support! We should see continued upswing today and setup for the next leg up and over the next week back over $3 for both Fannie and Freddie.
https://investorshub.advfn.com/uimage
FMCC
Trooperstocks Trooperstocks 14 minutes ago
A very promising 2025 is ahead for investors after listening to the Bloomberg report. $SGTM
SGTM
misterfishman misterfishman 14 minutes ago
Damn eagles the ravens did enough to win that game but Justin tucker the one time goat of a kicker left 7 points on the field if he had made just two out of the three he missed the ravens would have won inspite of the great defense of the eagles. I don't see the chiefs beating the eagles if they bot
IGPK
peafunke peafunke 15 minutes ago
Morning all!

🐔
TPTW